PEX7 antibody, N-term

GeneTex

PEX7 antibody, N-term

9

WB: 0.2-2.5 ug/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

Western Blot

Research Use Only

Polyclonal

0.5-1 mg/ml

Unconjugated

PEX7

peroxisomal biogenesis factor 7

PBD9B; peroxin-7; peroxisomal biogenesis factor 7; peroxisomal PTS2 receptor; peroxisomal targeting signal 2 receptor; peroxisome targeting signal 2 receptor; PTS2 receptor; PTS2R; RCDP1; RD

Rabbit

IgG

Peroxisomal targeting signal 2 receptor

This gene encodes the cytosolic receptor for the set of peroxisomal matrix enzymes targeted to the organelle by the peroxisome targeting signal 2 (PTS2). Defects in this gene cause peroxisome biogenesis disorders (PBDs), which are characterized by multiple defects in peroxisome function. There are at least 14 complementation groups for PBDs, with more than one phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene have been associated with PBD complementation group 11 (PBD-CG11) disorders, rhizomelic chondrodysplasia punctata type 1 (RCDP1), and Refsum disease (RD). [provided by RefSeq, Oct 2008]

Human

-20°C or -80°C,2°C to 8°C

12352203